News ItemIntroducing the 2012 NMBio Board of Directors

January 10, 2012 – 

NMBio is pleased to introduce our newly elected 2012 Board of Directors. Please see the NMBio Board of Directors page for more information about the Board.

John Cousins, President and CEO of Biomoda, Inc.. Vice President

Terry Dunlay, President and CEO of IntelliCyt Corporation

Victor Esch, CEO of NanoMR

David Hadley, Business Development Executive at Los Alamos National Labs

Michael Vickers, Maas Biolab

Stuart Rose, CEO, Oso Bio

Richard Larson, VP Translational Research at UNM Health Sciences Center

Charlotte Mobarak, Director of Proteomics and Mass Spectrometry at the Dept. of BioChemistry and Molecular Biology, UNM

Kimberly Peña, Principal at REDW LLC, The Rogoff Firm, Board Treasurer

Leah Pulling, Director of Biotechnology Program at Central New Mexico Community College

Andrew Salazar, Director of Project Development at Technology Ventures Corporation, NMBio President

Shannon Sheehan, PhD

Duane Simpson, Monsanto

Katie Szczepaniak Rice, Analyst at Wasatch Venture Fund

Janeen Vilven-Doggett, Attorney at Pacock Myers, P.C., Board Secretary

Mark Walztoni, Sustainable Ventures Alliance, LLC

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

Curia Global

Curia Global

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories

Colliers

Colliers